Immunotherapy: Clinical Trials

2 trials for Immunotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 suspended. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Suspended 2
Phase 21Suspended 1

Follow Immunotherapy: new trials by email Literature Review of Immunotherapy trials Research Report on Immunotherapy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer
Chemotherapy, Immunotherapy, IMRT - Rectal Cancer, Radiotherapy
Phase 1 / Phase 2SuspendedUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology302019-11-012024-01-03
Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malignancies
SHR-1603 - Physiological Effects of Drugs, Neoplasms by Histologic Type
Phase 1SuspendedJiangsu HengRui Medicine Co., Ltd.1282018-11-132021-03-22

Narrower conditions

Hematologic Neoplasms (1)  ·  Lymphoma (1)  ·  Neoplasms by Histologic Type (1)  ·  Rectal Neoplasms (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Colorectal Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)

Interventions

Drug Therapy (1)  ·  Immunotherapy (1)

Sponsors

Jiangsu HengRui Medicine Co., Ltd. (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)

Countries

China (2)